TA
Thomas Alexander
About Thomas Alexander
Data last updated:
Thomas Alexander is a Whole-Time Director at Sangrose Laboratories Private Limited (since 2002) and Director at Sangros Drugchem Private Limited (since 2015). The companies operate in Pharma and Chemicals and Materials. The largest current company by reported revenue is Sangrose Laboratories Private Limited at ₹32.28 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sangrose Laboratories Private Limited U24231KL1996PTC010099 | Whole-Time Director | 25 Feb 2002 | 1996 | ₹32.28 Cr (FY 2024) | Active |
 Sangros Drugchem Private Limited U24231KL1996PTC009906 | Director | 17 Jan 2015 | 1996 | Active |
Board colleagues of Thomas Alexander
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alexander Chackalamuriyil Kunjummen | 01267239 | Sangrose Laboratories Private Limited , Sangros Drugchem Private Limited | Managing Director |
| Chackalamuryil Kunjummen Joseph | 01968445 | Sangrose Laboratories Private Limited | Director |
| George Mathew | 01968774 | Sangrose Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thomas Alexander
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thomas Alexander
Thomas Alexander currently holds 2 directorships: Sangrose Laboratories Private Limited (Whole-Time Director, since 25 Feb 2002, revenue ₹32.28 Cr (FY 2024)); Sangros Drugchem Private Limited (Director, since 17 Jan 2015).
Thomas Alexander was first appointed on 25 Feb 2002 as Whole-Time Director at Sangrose Laboratories Private Limited. The most recent appointment on record is 17 Jan 2015 at Sangros Drugchem Private Limited.
The current boards of Thomas Alexander's companies include Alexander Chackalamuriyil Kunjummen (Sangrose Laboratories Private Limited), Chackalamuryil Kunjummen Joseph (Sangrose Laboratories Private Limited), George Mathew (Sangrose Laboratories Private Limited).